The International Contrast Ultrasound Society (ICUS) has urged the U.S. FDA to remove boxed warnings from ultrasound contrast agents based on research demonstrating its safety and clinical benefits.

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.

CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.

The U.S. Department of Justice (DOJ) Antitrust Division has cleared the $67 billion acquisition of Express Scripts by Cigna.

As part of its Patients Over Paperwork initiative, CMS has proposed another round of “red tape” cuts for healthcare providers that could reduce some burdens and loosen regulations across healthcare settings.

Jefferson Health and Einstein Healthcare Network have reached a definitive agreement to merge after previously announcing their intentions in March.

At a Sept. 12 Capitol Hill briefing, representatives from the American College of Radiology (ACR) discussed clinical and public health viewpoints for Medicare coverage of CT colonography (CTC) with staff members of about 30 senators and congressional representatives.